Combinatorial Patterns of Histone Acetylations and Methylations in the Human Genome

Total Page:16

File Type:pdf, Size:1020Kb

Combinatorial Patterns of Histone Acetylations and Methylations in the Human Genome LETTERS Combinatorial patterns of histone acetylations and methylations in the human genome Zhibin Wang1,5, Chongzhi Zang2,5, Jeffrey A Rosenfeld3–5, Dustin E Schones1, Artem Barski1, Suresh Cuddapah1, Kairong Cui1, Tae-Young Roh1, Weiqun Peng2, Michael Q Zhang3 & Keji Zhao1 Histones are characterized by numerous posttranslational level (see Methods section for data deposition), and analyzed these modifications that influence gene transcription1,2. However, together with the H2A.Z and 19 histone methylation maps we because of the lack of global distribution data in higher generated previously15. eukaryotic systems3, the extent to which gene-specific We first systematically evaluated the specificities of the acetylation combinatorial patterns of histone modifications exist remains antibodies used in this study (Supplementary Methods, Supplemen- to be determined. Here, we report the patterns derived from tary Table 1 and Supplementary Fig. 1 online). Competition assays the analysis of 39 histone modifications in human CD4+ using modified and unmodified peptides indicated that most anti- http://www.nature.com/naturegenetics T cells. Our data indicate that a large number of patterns bodies showed specificity for the desired acetylation (Supplementary are associated with promoters and enhancers. In particular, Fig. 1). The H4K5ac and H3K4ac antibodies demonstrated some we identify a common modification module consisting of 17 crossreactivity toward H4K12ac and H3K9ac, respectively, in a con- modifications detected at 3,286 promoters. These modifications dition with excess competitor peptides (Supplementary Fig. 1d,j), tend to colocalize in the genome and correlate with each other and the H4K91ac antibody did not work in protein blotting. Thus, the at an individual nucleosome level. Genes associated with this results for these modifications should be interpreted with caution. Of module tend to have higher expression, and addition of more note, H2AK9ac has not been reported previously, and H3K4ac has modifications to this module is associated with further only been identified by mass-spectrometry analysis and has not been increased expression. Our data suggest that these histone previously characterized functionally16. Protein blotting indicated that modifications may act cooperatively to prepare chromatin these acetylations indeed exist in human CD4+ T cells (Supplemen- for transcriptional activation. tary Fig. 1j,o). We previously analyzed the genome-wide distribution of H2BK5me1 (ref. 15), and protein blotting data in this study Histones are subject to numerous covalent modifications, including indicated that this methylation exists in human cells and that the © Group 2008 Nature Publishing methylation and acetylation, that occur mainly at their N-terminal H2BK5me1 antibody is specific (Supplementary Fig. 1p). tails and that can affect transcription of genes1,2,4,5. Extensive studies Next, we determined the genomic distribution patterns of these have established that histone acetylation is primarily associated with histone acetylations using the ChIP-Seq technique15, which we pre- gene activation, whereas methylation, depending on its position and viously confirmed yields H3K4me3 distribution patterns similar to state, is associated with either repression or activation5–10. Various those generated by the ChIP-SAGE (GMAT) strategy15,17. To validate models, including the histone code, the signaling network and the the histone acetylation data, we compared the genomic distribution charge neutralization model, have been proposed to account for the patterns of the K9/K14-diacetylated histone H3 from ChIP-SAGE18 function of histone modifications11–14. The histone code hypothesis with the separately examined patterns of H3K9ac and H3K14ac in suggests that multiple histone modifications act in a combinatorial this study (Supplementary Fig. 2 online). We found that the ChIP- fashion to specify distinct chromatin states. However, the extent to Seq acetylation data are reliable and that the previously observed which combinatorial patterns of histone modifications exist in H3K9/K14 diacetylation patterns could be primarily attributed to the genome is unknown. We have now produced genome-wide H3K9 acetylation. maps of 18 histone acetylations (H2AK5ac, H2AK9ac, H2BK5ac, To examine the distribution of the histone acetylations at different H2BK12ac, H2BK20ac, H2BK120ac, H3K4ac, H3K9ac, H3K14ac, functional regions, we generated composite profiles for the region H3K18ac, H3K23ac, H3K27ac, H3K36ac, H4K5ac, H4K8ac, spanning the transcription start sites (TSSs; Fig. 1a–c and Supple- H4K12ac, H4K16ac and H4K91ac) at an individual nucleosome mentary Fig. 3 online) or the entire gene bodies and extending 5 kb 1Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, US National Institutes of Health, Bethesda, Maryland 20892, USA. 2Department of Physics, The George Washington University, Washington, D.C. 20052, USA. 3Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA. 4Department of Biology, New York University, New York, New York 10003, USA. 5These authors contributed equally to this work. Correspondence should be addressed to K.Z. ([email protected]). Received 19 December 2007; accepted 1 April 2008; published online 15 June 2008; doi:10.1038/ng.154 NATURE GENETICS ADVANCE ONLINE PUBLICATION 1 LETTERS a d g H3K9ac H3K9ac ZMYND8 1.2E–07 High Chr20: Medium 8E–09 45250000 45300000 45350000 45400000 45450000 1E–07 High H3K4me3 96 Low 7E–09 Silent * H3K4me2 34 8E–08 Silent 6E–09 * H3K4me1 61 5E–09 * 6E–08 H3K4ac 18 4E–09 * H3K27me3 6 3E–09 4E–08 H3K27me2 5 2E–09 H3K27me1 15 Normalized counts 2E–08 Normalized counts 1E–09 * H3K27ac 54 * 0 0 H3K9me3 3 –2,000 –1,0000 1,000 2,000 0.1 0.2 0.3 0.4 0.500.600.700.800.90 H3K9me2 5 5 kb up txStart txEnd Position relative to TSS 2.5 kb up H3K9me1 32 5 kb down * 2.5 kb down H3K9ac 21 b e * H3K79me3 31 H3K23ac H3K23ac * 1.4E–08 High 2E–09 H3K79me2 25 High * 1.2E–08 Medium H3K79me1 13 Silent * Low H3R2me2 6 1E–08 1.5E–09 Silent H3R2me1 6 8E–09 1E–09 H3K36me3 25 6E–09 H3K36me1 6 H3K36ac 16 4E–09 5E–10 * H4K20me3 4 Normalized counts 2E–09 H4K20me1 29 0 0 H2BK5me1 35 0.1 0.2 0.3 0.4 –10,000 –5,0000 5,000 10,000 0.500.600.700.800.90 H2BK5ac 41 5 kb up txStart txEnd * 2.5 kb up H4R3me2 5 Position relative to TSS 5 kb down 2.5 kb down H3K14ac 5 * cf H3K18ac 47 H4K12ac H4K12ac * 2E–09 H3K23ac 10 1.6E–08 High High * H4K5ac 46 1.4E–08 Medium Silent * 1.5E–09 H4K8ac 47 * 1.2E–08 Low H4K12ac 8 1E–08 Silent * H4K16ac 12 1E–09 * 8E–09 H4K91ac 35 * 6E–09 H2BK12ac 9 5E–10 * H2BK20ac 22 4E–09 Normalized counts Normalized counts * H2BK120ac 24 Normalized counts 2E–09 0 * H2AK5ac 10 0.1 0.2 0.3 0.4 0 0.500.600.700.800.90 H2AK9ac 4 –10,000 –5,0000 5,000 10,000 5 kb up txStart txEnd 2.5 kb up H2A.Z 39 5 kb down * Position relative to TSS 2.5 kb down Figure 1 Three distribution patterns of histone acetylations. (a–c) Normalized tag counts of histone acetylation signals surrounding the TSS were indicated http://www.nature.com/naturegenetics for highly active, intermediately active (two levels) and silent genes. Each group represents 1,000 genes with similar expression, as described in Methods. (d–f) Normalized tag counts of histone acetylation signals of 1,000 highly active or silent genes across the gene bodies. The plots extend 5 kb 5¢ and 3¢ of the genic regions (see Methods). txStart, transcription start site; txEnd, transcription end. (g) Chromatin modification patterns at the ZMYND8 (PRKCBP1) gene locus. Significant modifications in the –1 kb to +1 kb region surrounding the TSS (P o 10À7; highlighted in red) are indicated by asterisks on the left. upstream and 5 kb downstream for groups of 1,000 genes according to H4K5ac, H4K8ac, H4K12ac and H4K16ac are elevated in the promoter their expression (Fig. 1d–f and Supplementary Fig. 4 online). We and transcribed regions of active genes (Fig. 1f and Supplementary found that all acetylations positively correlated with gene expression, Fig. 4). These results are consistent with previous reports that specific consistent with their involvement in tran- scriptional activation. However, our data indicate that different acetylations may target a c 2 10,000 different regions of genes. For example, 1.5 H2AK9ac, H2BK5ac, H3K9ac, H3K18ac, 1,000 1 © Group 2008 Nature Publishing H3K27ac, H3K36ac and H4K91ac are mainly 0.5 ) located in the region surrounding the TSS 100 2 0 (log (Fig. 1d and Supplementary Fig. 4), whereas patterns –0.5 10 H2BK12ac, H2BK20ac, H2BK120ac, H3K4ac, –1 Number of combinatorial –1.5 1 Fold change in expression 1 10 100 1,000 10,000 Number of genes associated H2A.Z H4K5ac H4K8ac with the same pattern H3K4ac H3K9ac H4K12ac H4K16ac H4K91ac H3K14ac H3K18ac H3K23ac H3K27ac H3K36ac H2AK9ac H2AK5ac H2BK5ac H3K4me1 H3K4me2 H3K4me3 H3K9me1 H3K9me2 H3K9me3 Figure 2 Patterns of histone modifications H3R2me1 H3R2me2 H2BK12ac H2BK20ac H4K20me1 H4K20me3 H3K27me1 H3K27me2 H3K27me3 H3K36me1 H3K36me3 H3K79me1 H3K79me2 H3K79me3 H2BK5me1 associated with promoters. (a) Patterns of histone b 100 H2BK120ac modifications at promoters. The y axis indicates B,H2AK9ac,H2BK5me1,H3K79me1,me2,me3,H4K12ac,H4K16ac,H4K20me1:62 90 B,H2AK9ac,H2BK5me1,H3K79me1,me2,me3,H4K16ac,H4K20me1:68 III the number of patterns of 39 histone B,H2BK5me1,H3K79me1,me2,me3,H4K16ac,H4K20me1:74 modifications (see Methods), and the x axis 80 B,H4K16ac:67 B:64 II indicates the number of promoters associated 70 H3K36me3:135 with each pattern. (b) Correlation of gene H2AZ,H3K4me1,me2,me3,H3K9me1,H3K27me3:77 H2AZ,H3K4me2,me3,H3K9me1,H3K27me3:70 expression with the thirteen most prevalent 60 H2AZ,H3K4me3,H3K27me3:74 I modification patterns. B, the 17-modification H3K4me3,H3K27me3:167 50 H3K4me3:85 backbone; All, all genes. The number of H3K27me3:630 promoters within each pattern is also indicated.
Recommended publications
  • Functional Roles of Bromodomain Proteins in Cancer
    cancers Review Functional Roles of Bromodomain Proteins in Cancer Samuel P. Boyson 1,2, Cong Gao 3, Kathleen Quinn 2,3, Joseph Boyd 3, Hana Paculova 3 , Seth Frietze 3,4,* and Karen C. Glass 1,2,4,* 1 Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Colchester, VT 05446, USA; [email protected] 2 Department of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA; [email protected] 3 Department of Biomedical and Health Sciences, University of Vermont, Burlington, VT 05405, USA; [email protected] (C.G.); [email protected] (J.B.); [email protected] (H.P.) 4 University of Vermont Cancer Center, Burlington, VT 05405, USA * Correspondence: [email protected] (S.F.); [email protected] (K.C.G.) Simple Summary: This review provides an in depth analysis of the role of bromodomain-containing proteins in cancer development. As readers of acetylated lysine on nucleosomal histones, bromod- omain proteins are poised to activate gene expression, and often promote cancer progression. We examined changes in gene expression patterns that are observed in bromodomain-containing proteins and associated with specific cancer types. We also mapped the protein–protein interaction network for the human bromodomain-containing proteins, discuss the cellular roles of these epigenetic regu- lators as part of nine different functional groups, and identify bromodomain-specific mechanisms in cancer development. Lastly, we summarize emerging strategies to target bromodomain proteins in cancer therapy, including those that may be essential for overcoming resistance. Overall, this review provides a timely discussion of the different mechanisms of bromodomain-containing pro- Citation: Boyson, S.P.; Gao, C.; teins in cancer, and an updated assessment of their utility as a therapeutic target for a variety of Quinn, K.; Boyd, J.; Paculova, H.; cancer subtypes.
    [Show full text]
  • Four Enzymes Cooperate to Displace Histone H1 During the First Minute of Hormonal Gene Activation
    Downloaded from genesdev.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation Guillermo Pablo Vicent,1,2 A. Silvina Nacht,1 Jofre Font-Mateu, Giancarlo Castellano, Laura Gaveglia, Cecilia Ballare´, and Miguel Beato Centre de Regulacio´ Geno` mica (CRG), Universitat Pompeu Fabra (UPF), E-08003 Barcelona, Spain Gene regulation by external signals requires access of transcription factors to DNA sequences of target genes, which is limited by the compaction of DNA in chromatin. Although we have gained insight into how core histones and their modifications influence this process, the role of linker histones remains unclear. Here we show that, within the first minute of progesterone action, a complex cooperation between different enzymes acting on chromatin mediates histone H1 displacement as a requisite for gene induction and cell proliferation. First, activated progesterone receptor (PR) recruits the chromatin remodeling complexes NURF and ASCOM (ASC-2 [activating signal cointegrator-2] complex) to hormone target genes. The trimethylation of histone H3 at Lys 4 by the MLL2/MLL3 subunits of ASCOM, enhanced by the hormone-induced displacement of the H3K4 demethylase KDM5B, stabilizes NURF binding. NURF facilitates the PR-mediated recruitment of Cdk2/CyclinA, which is required for histone H1 displacement. Cooperation of ATP-dependent remodeling, histone methylation, and kinase activation, followed by H1 displacement, is a prerequisite for the subsequent displacement of histone H2A/H2B catalyzed by PCAF and BAF. Chromatin immunoprecipitation (ChIP) and sequencing (ChIP-seq) and expression arrays show that H1 displacement is required for hormone induction of most hormone target genes, some of which are involved in cell proliferation.
    [Show full text]
  • Subcloning, Expression, and Enzymatic Study of PRMT5
    Georgia State University ScholarWorks @ Georgia State University Biology Theses Department of Biology Summer 7-12-2010 Subcloning, Expression, and Enzymatic Study of PRMT5 Ran Guo Georgia State University Follow this and additional works at: https://scholarworks.gsu.edu/biology_theses Part of the Biology Commons Recommended Citation Guo, Ran, "Subcloning, Expression, and Enzymatic Study of PRMT5." Thesis, Georgia State University, 2010. https://scholarworks.gsu.edu/biology_theses/26 This Thesis is brought to you for free and open access by the Department of Biology at ScholarWorks @ Georgia State University. It has been accepted for inclusion in Biology Theses by an authorized administrator of ScholarWorks @ Georgia State University. For more information, please contact [email protected]. SUBCLONING, EXPRESSION, AND ENZYMATIC STUDY OF PRMT5 by RAN GUO Under the Direction of Yujun George Zheng ABSTRACT Protein arginine methyltransferases (PRMTs) mediate the transfer of methyl groups to arginine residues in histone and non-histone proteins. PRMT5 is an important member of PRMTs which symmetrically dimethylates arginine 8 in histone H3 (H3R8) and arginine 3 in histone H4 (H4R3). PRMT5 was reported to inhibit some tumor suppressors in leukemia and lymphoma cells and regulate p53 gene, through affecting the promoter of p53. Through methylation of H4R3, PRMT5 can recruit DNA-methyltransferase 3A (DNMT3A) which regulates gene transcription. All the above suggest that PRMT5 has an important function of suppressing cell apoptosis and is a potential anticancer target. Currently, the enzymatic activities of PRMT5 are not clearly understood. In our study, we improved the protein expression methodology and greatly enhanced the yield and quality of the recombinant PRMT5.
    [Show full text]
  • Quantitative Proteomics Methods for the Analysis of Histone Post-Translational Modifications
    Université de Montréal Quantitative Proteomics Methods for the Analysis of Histone Post-translational Modifications par Nebiyu Ali Abshiru Département de Chimie Faculté des arts et des sciences Thèse présentée à la Faculté des études supérieures et postdoctorales en vue de l’obtention du grade de philosophiae doctor (Ph.D.) en chimie Septembre 2015 ©Nebiyu Ali Abshiru, 2015 i Résumé Les histones sont des protéines nucléaires hautement conservées chez les cellules des eucaryotes. Elles permettent d’organiser et de compacter l’ADN sous la forme de nucléosomes, ceux-ci representant les sous unités de base de la chromatine. Les histones peuvent être modifiées par de nombreuses modifications post-traductionnelles (PTMs) telles que l’acétylation, la méthylation et la phosphorylation. Ces modifications jouent un rôle essentiel dans la réplication de l’ADN, la transcription et l’assemblage de la chromatine. L’abondance de ces modifications peut varier de facon significative lors du developpement des maladies incluant plusieurs types de cancer. Par exemple, la perte totale de la triméthylation sur H4K20 ainsi que l’acétylation sur H4K16 sont des marqueurs tumoraux spécifiques a certains types de cancer chez l’humain. Par conséquent, l’étude de ces modifications et des événements determinant la dynamique des leurs changements d’abondance sont des atouts importants pour mieux comprendre les fonctions cellulaires et moléculaires lors du développement de la maladie. De manière générale, les modifications des histones sont étudiées par des approches biochimiques telles que les immuno-buvardage de type Western ou les méthodes d’immunoprécipitation de la chromatine (ChIP). Cependant, ces approches présentent plusieurs inconvénients telles que le manque de spécificité ou la disponibilité des anticorps, leur coût ou encore la difficulté de les produire et de les valider.
    [Show full text]
  • Inferring Causal Relationships Among Different Histone Modifications and Gene Expression
    Downloaded from genome.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press Inferring Causal Relationships among Different Histone Modifications and Gene Expression Hong Yu*, Shanshan Zhu*, Bing Zhou*, Huiling Xue and Jing-Dong J. Han Chinese Academy of Sciences Key Laboratory of Molecular Developmental Biology, Center for Molecular Systems Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Datun Road, Beijing, 100101, China * These authors contributed equally to this work. Correspondence should be addressed to J.-D.J.H ([email protected]). Running title: histone modification and gene expression network Keywords: histone modification, gene expression, Bayesian network, causal relationship, epigenetics 1 Downloaded from genome.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press Abstract Histone modifications are major epigenetic factors regulating gene expression. They play important roles in maintaining stem cell pluripotency and in cancer pathogenesis. Different modifications may combine to form complex ‘histone codes’. Recent high throughput technologies, such as ‘ChIP-chip’ and ‘ChIP-seq’, have generated high resolution maps for many histone modifications on the human genome. Here we use these maps to build a Bayesian network to infer causal and combinatorial relationships among histone modifications and gene expression. A pilot network derived by the same method among polycomb group (PcG) genes and H3K27 trimethylation is accurately supported by current literature. Our unbiased network model among histone modifications is also well supported by cross validation results. It not only confirmed already known relationships, such as those of H3K27me3 to gene silencing, H3K4me3 to gene activation, and the effect of bivalent modification of both H3K4me3 and H3K27me3, but also identified many other relationships that may predict new epigenetic interactions important in epigenetic gene regulation.
    [Show full text]
  • Anti-H3r2me2(Asym) Antibody
    FOR RESEARCH USE ONLY! 01/20 Anti-H3R2me2(asym) Antibody CATALOG NO.: A2025-100 (100 µl) BACKGROUND DESCRIPTION: Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Nucleosomes consist of approximately 146 bp of DNA wrapped around a histone octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. This gene is intronless and encodes a replication-dependent histone that is a member of the histone H3 family. Transcripts from this gene lack poly A tails; instead, they contain a palindromic termination element. This gene is located separately from the other H3 genes that are in the histone gene cluster on chromosome 6p22-p21.3. H3.4; H3/g; H3FT; H3t; HIST3H3; Histone H3; HIST1H3A ALTERNATE NAMES: ANTIBODY TYPE: Polyclonal HOST/ISOTYPE: Rabbit / IgG IMMUNOGEN: A synthetic methylated peptide targeting residues around Arginine 2 of human Histone H3 MOLECULAR WEIGHT: 17 kDa PURIFICATION: Affinity purified FORM: Liquid FORMULATION: In PBS with 0.02% sodium azide, 50% glycerol, pH 7.3 SPECIES REACTIVITY: Human, Mouse, Rat STORAGE CONDITIONS: Store at -20ºC. Avoid freeze / thaw cycles APPLICATIONS AND USAGE: WB 1:500 - 1:2000, IHC 1:50 - 1:200, IF 1:50 - 1:200 Note: This information is only intended as a guide. The optimal dilutions must be determined by the user Western blot analysis of H3R2me2(asym) expression in Dot-blot analysis of methylation peptides using Anti- HeLa cells and H3 protein.
    [Show full text]
  • PCAF-Dependent Epigenetic Changes Promote Axonal Regeneration in the Central Nervous System
    ARTICLE Received 13 Dec 2013 | Accepted 27 Feb 2014 | Published 1 Apr 2014 DOI: 10.1038/ncomms4527 PCAF-dependent epigenetic changes promote axonal regeneration in the central nervous system Radhika Puttagunta1,*, Andrea Tedeschi2,*, Marilia Grando So´ria1,3, Arnau Hervera1,4, Ricco Lindner1,3, Khizr I. Rathore1, Perrine Gaub1,3, Yashashree Joshi1,3,5, Tuan Nguyen1, Antonio Schmandke1, Claudia J. Laskowski2, Anne-Laurence Boutillier6, Frank Bradke2 & Simone Di Giovanni1,4 Axonal regenerative failure is a major cause of neurological impairment following central nervous system (CNS) but not peripheral nervous system (PNS) injury. Notably, PNS injury triggers a coordinated regenerative gene expression programme. However, the molecular link between retrograde signalling and the regulation of this gene expression programme that leads to the differential regenerative capacity remains elusive. Here we show through systematic epigenetic studies that the histone acetyltransferase p300/CBP-associated factor (PCAF) promotes acetylation of histone 3 Lys 9 at the promoters of established key regeneration-associated genes following a peripheral but not a central axonal injury. Furthermore, we find that extracellular signal-regulated kinase (ERK)-mediated retrograde signalling is required for PCAF-dependent regenerative gene reprogramming. Finally, PCAF is necessary for conditioning-dependent axonal regeneration and also singularly promotes regeneration after spinal cord injury. Thus, we find a specific epigenetic mechanism that regulates axonal regeneration of CNS axons, suggesting novel targets for clinical application. 1 Laboratory for NeuroRegeneration and Repair, Center for Neurology, Hertie Institute for Clinical Brain Research, University of Tu¨bingen, 72076 Tu¨bingen, Germany. 2 Department of Axonal Growth and Regeneration, German Center for Neurodegenerative Disease, 53175 Bonn, Germany.
    [Show full text]
  • Histone H3K4 Demethylation Is Negatively Regulated by Histone H3 Acetylation in Saccharomyces Cerevisiae
    Histone H3K4 demethylation is negatively regulated by histone H3 acetylation in Saccharomyces cerevisiae Vicki E. Maltbya, Benjamin J. E. Martina, Julie Brind’Amourb,1, Adam T. Chruscickia,1, Kristina L. McBurneya, Julia M. Schulzec, Ian J. Johnsona, Mark Hillsd, Thomas Hentrichc, Michael S. Koborc, Matthew C. Lorinczb, and LeAnn J. Howea,2 Departments of aBiochemistry and Molecular Biology and bMedical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada V6T 1Z3; cCenter for Molecular Medicine and Therapeutics, Child and Family Research Institute, Vancouver, BC, Canada V5Z 4H4; and dTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada V5Z 1L3 Edited by Kevin Struhl, Harvard Medical School, Boston, MA, and approved September 12, 2012 (received for review February 6, 2012) Histone H3 lysine 4 trimethylation (H3K4me3) is a hallmark of of lysine-specific HDMs have been identified: amine oxidases, transcription initiation, but how H3K4me3 is demethylated during such as LSD1, and the JmjC (Jumonji C) domain–containing gene repression is poorly understood. Jhd2, a JmjC domain protein, demethylases. This latter class of demethylases can be split fur- was recently identified as the major H3K4me3 histone demethylase ther into several subfamilies, including the evolutionarily con- (HDM) in Saccharomyces cerevisiae. Although JHD2 is required for served JARID1 family of demethylases, which is characterized JHD2 removal of methylation upon gene repression, deletion of does not only by a JmjC domain but also by JmjN, AT-rich interactive, not result in increased levels of H3K4me3 in bulk histones, indicating C5HC2 zinc finger, and PHD finger domains (6). In the yeast S. that this HDM is unable to demethylate histones during steady-state cerevisiae, the lone member of the JARID1 family of demethy- conditions.
    [Show full text]
  • MAP3K4/CBP-Regulated H2B Acetylation Controls Epithelial-Mesenchymal Transition in Trophoblast Stem Cells
    Cell Stem Cell Article MAP3K4/CBP-Regulated H2B Acetylation Controls Epithelial-Mesenchymal Transition in Trophoblast Stem Cells Amy N. Abell,1,2,7,* Nicole Vincent Jordan,1,2,7 Weichun Huang,6 Aleix Prat,2,4 Alicia A. Midland,5 Nancy L. Johnson,1,2 Deborah A. Granger,1,2 Piotr A. Mieczkowski,2,3 Charles M. Perou,2,4 Shawn M. Gomez,5 Leping Li,6 and Gary L. Johnson1,2,* 1Department of Pharmacology 2Lineberger Comprehensive Cancer Center 3Department of Genetics and Carolina Center for Genome Sciences 4Department of Genetics 5Department of Biomedical Engineering and Curriculum in Bioinformatics and Computational Biology University of North Carolina School of Medicine, Chapel Hill, NC 27599-7365, USA 6Biostatistics Branch, National Institute of Environmental Health Sciences RTP, NC 27709, USA 7These authors contributed equally to this work *Correspondence: [email protected] (A.N.A.), [email protected] (G.L.J.) DOI 10.1016/j.stem.2011.03.008 SUMMARY berg, 2008). During development, EMT is responsible for proper formation of the body plan and for differentiation of many tissues Epithelial stem cells self-renew while maintaining and organs. Examples of EMT in mammalian development multipotency, but the dependence of stem cell prop- include implantation, gastrulation, and neural crest formation erties on maintenance of the epithelial phenotype is (Thiery et al., 2009). Initiation of placenta formation regulated unclear. We previously showed that trophoblast by trophoectoderm differentiation is the first, and yet most poorly stem (TS) cells lacking the protein kinase MAP3K4 defined, developmental EMT. maintain properties of both stemness and epithelial- The commitment of stem cells to specialized cell types requires extensive reprogramming of gene expression, involving, in part, mesenchymal transition (EMT).
    [Show full text]
  • Recognition of Histone Acetylation by the GAS41 YEATS Domain Promotes H2A.Z Deposition in Non-Small Cell Lung Cancer
    Downloaded from genesdev.cshlp.org on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer Chih-Chao Hsu,1,2,8 Jiejun Shi,3,8 Chao Yuan,1,2,7,8 Dan Zhao,4,5,8 Shiming Jiang,1,2 Jie Lyu,3 Xiaolu Wang,1,2 Haitao Li,4,5 Hong Wen,1,2 Wei Li,3 and Xiaobing Shi1,2,6 1Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; 2Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; 3Dan L. Duncan Cancer Center, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA; 4MOE Key Laboratory of Protein Sciences, Beijing Advanced Innovation Center for Structural Biology, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China; 5Tsinghua-Peking Joint Center for Life Sciences, Tsinghua University, Beijing 100084, China; 6Genetics and Epigenetics Graduate Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas 77030, USA Histone acetylation is associated with active transcription in eukaryotic cells. It helps to open up the chromatin by neutralizing the positive charge of histone lysine residues and providing binding platforms for “reader” proteins. The bromodomain (BRD) has long been thought to be the sole protein module that recognizes acetylated histones. Re- cently, we identified the YEATS domain of AF9 (ALL1 fused gene from chromosome 9) as a novel acetyl-lysine- binding module and showed that the ENL (eleven-nineteen leukemia) YEATS domain is an essential acetyl-histone reader in acute myeloid leukemias.
    [Show full text]
  • SETD2 Mutations in Primary Central Nervous System Tumors Angela N
    Viaene et al. Acta Neuropathologica Communications (2018) 6:123 https://doi.org/10.1186/s40478-018-0623-0 RESEARCH Open Access SETD2 mutations in primary central nervous system tumors Angela N. Viaene1, Mariarita Santi1, Jason Rosenbaum2, Marilyn M. Li1, Lea F. Surrey1 and MacLean P. Nasrallah2,3* Abstract Mutations in SETD2 are found in many tumors, including central nervous system (CNS) tumors. Previous work has shown these mutations occur specifically in high grade gliomas of the cerebral hemispheres in pediatric and young adult patients. We investigated SETD2 mutations in a cohort of approximately 640 CNS tumors via next generation sequencing; 23 mutations were detected across 19 primary CNS tumors. Mutations were found in a wide variety of tumors and locations at a broad range of allele frequencies. SETD2 mutations were seen in both low and high grade gliomas as well as non-glial tumors, and occurred in patients greater than 55 years of age, in addition to pediatric and young adult patients. High grade gliomas at first occurrence demonstrated either frameshift/truncating mutations or point mutations at high allele frequencies, whereas recurrent high grade gliomas frequently harbored subclones with point mutations in SETD2 at lower allele frequencies in the setting of higher mutational burdens. Comparison with the TCGA dataset demonstrated consistent findings. Finally, immunohistochemistry showed decreased staining for H3K36me3 in our cohort of SETD2 mutant tumors compared to wildtype controls. Our data further describe the spectrum of tumors in which SETD2 mutations are found and provide a context for interpretation of these mutations in the clinical setting. Keywords: SETD2, Histone, Brain tumor, Glioma, Epigenetics, H3K36me3 Introduction (H3K36me3) in humans.
    [Show full text]
  • Deciphering the Histone Code to Build the Genome Structure
    bioRxiv preprint doi: https://doi.org/10.1101/217190; this version posted November 20, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Deciphering the histone code to build the genome structure Kirti Prakasha,b,c,* and David Fournierd,* aPhysico-Chimie Curie, Institut Curie, CNRS UMR 168, 75005 Paris, France; bOxford Nanoimaging Ltd, OX1 1JD, Oxford, UK; cMicron Advanced Bioimaging Unit, Department of Biochemistry, University of Oxford, Oxford, UK; dFaculty of Biology and Center for Computational Sciences, Johannes Gutenberg University Mainz, 55128 Mainz, Germany; *Correspondence: [email protected], [email protected] Histones are punctuated with small chemical modifications that alter their interaction with DNA. One attractive hypothesis stipulates that certain combinations of these histone modifications may function, alone or together, as a part of a predictive histone code to provide ground rules for chromatin folding. We consider four features that relate histone modifications to chromatin folding: charge neutrali- sation, molecular specificity, robustness and evolvability. Next, we present evidence for the association among different histone modi- fications at various levels of chromatin organisation and show how these relationships relate to function such as transcription, replica- tion and cell division. Finally, we propose a model where the histone code can set critical checkpoints for chromatin to fold reversibly be- tween different orders of the organisation in response to a biological stimulus. DNA | nucleosomes | histone modifications | chromatin domains | chro- mosomes | histone code | chromatin folding | genome structure Introduction The genetic information within chromosomes of eukaryotes is packaged into chromatin, a long and folded polymer of double-stranded DNA, histones and other structural and non- structural proteins.
    [Show full text]